EZZ Life Science Holdings Limited (ASX:EZZ)

Australia flag Australia · Delayed Price · Currency is AUD
1.045
+0.015 (1.46%)
Mar 10, 2026, 10:01 AM AEST
-39.60%
Market Cap 48.48M
Revenue (ttm) 61.40M
Net Income (ttm) 2.89M
Shares Out 47.07M
EPS (ttm) 0.06
PE Ratio 16.79
Forward PE n/a
Dividend 0.04 (3.69%)
Ex-Dividend Date Nov 24, 2025
Volume 562
Average Volume 27,926
Open 1.045
Previous Close 1.030
Day's Range 1.045 - 1.045
52-Week Range 1.030 - 3.380
Beta 0.49
RSI 22.32
Earnings Date Feb 26, 2026

About EZZ Life Science Holdings

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand. It also offers its products online. Th... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol EZZ
Full Company Profile

Financial Performance

In fiscal year 2025, EZZ Life Science Holdings's revenue was 66.87 million, an increase of 0.65% compared to the previous year's 66.44 million. Earnings were 6.73 million, a decrease of -3.36%.

Financial Statements

News

There is no news available yet.